Valid for Submission
C25.3 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of pancreatic duct. The code C25.3 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C25.3 might also be used to specify conditions or terms like adenocarcinoma of pancreas, malignant tumor of pancreatic duct, pancreatic ductal adenocarcinoma, primary adenocarcinoma of pancreas or primary malignant neoplasm of pancreatic duct.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: pancreas duct (of Santorini) (of Wirsung) or Santorini's duct or Wirsung's duct .
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adenocarcinoma of pancreas
- Malignant tumor of pancreatic duct
- Pancreatic ductal adenocarcinoma
- Primary adenocarcinoma of pancreas
- Primary malignant neoplasm of pancreatic duct
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|435||MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC||07||1.7528|
|436||MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC||07||1.1202|
|437||MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC||07||0.8945|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert C25.3 to ICD-9 Code
Table of Neoplasms
The code C25.3 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
»duct (of Santorini) (of Wirsung)
Information for Patients
The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control blood sugar levels. Pancreatic cancer usually begins in the cells that produce the juices. Some risk factors for developing pancreatic cancer include
- Long-term diabetes
- Chronic pancreatitis
- Certain hereditary disorders
Pancreatic cancer is hard to catch early. It doesn't cause symptoms right away. When you do get symptoms, they are often vague or you may not notice them. They include yellowing of the skin and eyes, pain in the abdomen and back, weight loss and fatigue. Also, because the pancreas is hidden behind other organs, health care providers cannot see or feel the tumors during routine exams. Doctors use a physical exam, blood tests, imaging tests, and a biopsy to diagnose it.
Because it is often found late and it spreads quickly, pancreatic cancer can be hard to treat. Possible treatments include surgery, radiation, chemotherapy, and targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Pancreatic Cancer Summary Learn about pancreatic cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]